Toxicities after Radioembolization with Yttrium-90 SIR-Spheres: Incidence and Contributing Risk Factors at a Single Center-Reference-Cited by-同舟云学术

Toxicities after Radioembolization with Yttrium-90 SIR-Spheres: Incidence and Contributing Risk Factors at a Single Center

Published:2011-10 Issue:10 Volume:22 Page:1373-1379
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Piana Peachy Mae,Gonsalves Carin F.,Sato Takami,Anne P. Rani,McCann Jeffrey W.,Bar Ad Voichita,Eschelman David J.,Parker Laurence,Doyle Laura A.,Brown Daniel B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference26 articles.

1. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors;Kennedy;Int J Radiat Oncol Biol Phys,2009

2. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes;Salem;Gastroenterology,2010

3. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma;Sangro;Int J Radiat Oncol Biol Phys,2006

4. Liver disease induced by radioembolization of liver tumors: description and possible risk factors;Sangro;Cancer,2008

5. Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: initial outcomes;Stuart;J Vasc Interv Radiol,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Selective Internal Radionuclide Therapy with 90Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization;Pharmaceuticals;2024-01-11

2. Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature;Diagnostics;2023-12-12

3. Current Developments of Selective Internal Radiotherapy (SIRT) in Germany: A Systematic Analysis of Indication and Hospital Mortality between 2012 and 2019;2022-10-17

4. Intrahepatic flow diversion prior to segmental Yttrium-90 radioembolization for challenging tumor vasculature;Journal of Interventional Medicine;2022-05

5. Repeated Transarterial Radioembolization Adverse Event and Hepatotoxicity Profile in Cirrhotic Patients With Hepatocellular Carcinoma: A Single-Center Experience;Cureus;2022-03-28